Literature DB >> 7087045

Treatment of a metastatic prostate derived tumor with surgery and chemotherapy.

D Kadmon, W D Heston, W R Fair.   

Abstract

The R3327/MAT-Lu tumor is a metastasizing variant of the Dunning R3327 Copenhagen rat prostatic carcinoma which, when implanted subcutaneously in the flank or intramuscularly in the hind leg, invariably metastasizes to the lungs. We examined treatment with either single dose chemotherapy, surgical excision of the primary tumor, or a combination of tumor excision and postoperative single dose chemotherapy. All 3 regimens significantly reduced the number of lung metastases; however, only the combination of tumor excision, followed by postoperative chemotherapy substantially prolonged survival and produced cures.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7087045     DOI: 10.1016/s0022-5347(17)54306-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?

Authors:  Romain Mathieu; Stephan M Korn; Karim Bensalah; Gero Kramer; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-08-08       Impact factor: 4.226

2.  Evaluation of the antitumour activity of coumarin in prostate cancer models.

Authors:  A Maucher; M Kager; E von Angerer
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Antitumour activity of coumarin in prostate and mammary cancer models.

Authors:  E von Angerer; M Kager; A Maucher
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Prospective serial liver ultrasound scanning in resectable colorectal cancer treated with adjuvant razoxane.

Authors:  R H Taylor; J M Gilbert; M G Evans; H G Lane; P G Cassell
Journal:  Clin Exp Metastasis       Date:  1984 Oct-Dec       Impact factor: 5.150

Review 5.  Cytoreductive prostatectomy: evidence in support of a new surgical paradigm (Review).

Authors:  Izak Faiena; Eric A Singer; Chris Pumill; Isaac Y Kim
Journal:  Int J Oncol       Date:  2014-09-17       Impact factor: 5.650

6.  MRI should be routine for all patients with localized prostate cancer? | Opinion: Yes.

Authors:  Ronaldo Hueb Baroni
Journal:  Int Braz J Urol       Date:  2016 Nov-Dec       Impact factor: 1.541

7.  Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes.

Authors:  Walter Henriques da Costa; Gustavo Cardoso Guimarães
Journal:  Int Braz J Urol       Date:  2016 Sep-Oct       Impact factor: 1.541

Review 8.  Cytoreductive treatment strategies for de novo metastatic prostate cancer.

Authors:  Martin J Connor; Taimur T Shah; Gail Horan; Charlotte L Bevan; Mathias Winkler; Hashim U Ahmed
Journal:  Nat Rev Clin Oncol       Date:  2019-11-11       Impact factor: 66.675

9.  Metastasizing, Luciferase Transduced MAT‑Lu Rat Prostate Cancer Models: Follow up of Bolus and Metronomic Therapy with Doxorubicin as Model Drug.

Authors:  Peter Jantscheff; Norbert Esser; Andreas Geipel; Peter Woias; Vittorio Ziroli; Frank Goldschmidtboing; Ulrich Massing
Journal:  Cancers (Basel)       Date:  2011-06-17       Impact factor: 6.639

10.  Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No.

Authors:  Benjamin T Ristau; Marc C Smaldone
Journal:  Int Braz J Urol       Date:  2016 Sep-Oct       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.